ScholarIQanswers from OpenAlex

Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease

PaperCitations, authors & open-access status

Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease have?

ScholarIQcitation count

Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease has 49 citations in the OpenAlex counts ScholarIQ stores.

When was Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease published?

ScholarIQyear

Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease has 2004 year in the ScholarIQ index.

What is the open-access status of Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease?

ScholarIQoa status

Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease has closed oa status in the ScholarIQ index.

What is the DOI of Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease?

ScholarIQdoi

The DOI for Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease is on the source record.

What is the PMID of Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease?

ScholarIQpmid

The PMID for Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease is on the source record.

What is the OpenAlex record for Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease?

ScholarIQopenalex

The OpenAlex for Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial